High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 12/16/19

High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 12/10/19

Topics discussed:

Is it OK for PSA to stabilize in the 20’s?; debulking the Primary tumor and iterating metastatic cells; repeating bicalutamide use; anti-fatigue drugs; generic abiraterone; shingles vaccines; HERO trial for relugolix; switching LHRH drugs; monotherapy anti-androgen treatment; using Technitium99 scan for darolutamide; can your MSI change over time?; pembrolizumab for PCa; your doctor’s attitude to you and your treatment; separating designated resources in your final wishes.

To view links referenced in this recording, please visit our Prostate Cancer Forum

Navigating Prostate Cancer: Diagnosis Through Survivorship – interview with Rick Davis

Navigating Prostate Cancer: Diagnosis Through Survivorship – interview with Rick Davis

Navigating Prostate Cancer: Diagnosis Through Survivorship

Through my attendance at HealtheVoices 2019, I had the good fortune to meet Andrew Schorr, the founder of Patient Power. In their own words…… Patient Power® is devoted to supporting cancer patients, care partners and other loved ones through education and advocacy – to get the right treatment at the right time working with the right healthcare team.

A couple of months later I was approached to do an interview with their Prostate Cancer Community Manager, Andrea Hutton that I just learned was published on their PCa page in October. You can watch for yourself by clicking on this link ; hopefully for our veterans, there won’t be too much new. And from my standpoint, it’s a great visual lesson in how to improve my interviewing technique!!

High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 12/16/19

High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 11/26/19

Topics discussed:

Remembering Thibeaux Lincecum; SSDI approval won; new NHI PSMA initiatives – scan & curative; Paget’s Disease confused with PCa; bone biopsy protocol; biopsy slide preparation; denosumab – Xgeva v Prolia; PCRI recordings; recovering from RRP; our own mortality; does testosterone recovery impact PSA readings; glucose and PCa